Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1476 studies found for:    rituximab
Show Display Options
Rank Status Study
1 Withdrawn Rituximab for GVHD
Conditions: Graft vs Host Disease;   Alogenic Hematopoietic Transplant
Intervention: Drug: Rituximab
2 Completed Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab
Conditions: Humoral Acute Refection of Renal Transplant;   Autoimmune Diseases
Interventions: Drug: Rituximab 375;   Drug: rituximab 1000
3 Terminated
Has Results
Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia
Conditions: Leukemia;   Acute Lymphoblastic Leukemia;   ALL
Intervention: Drug: rituximab
4 Unknown  Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Interventions: Drug: lenalidomide-low dose dexamethasone plus rituximab;   Drug: Lenalidomide + Rituximab
5 Completed
Has Results
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Conditions: Anemia, Aplastic;   Red-Cell Aplasia, Pure;   Anemia, Diamond-Blackfan
Intervention: Drug: Rituximab
6 Not yet recruiting B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Rituximab;   Drug: Placebo
7 Terminated
Has Results
Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura
Interventions: Drug: Rituximab;   Procedure: Plasma exchange;   Drug: Corticosteroids
8 Completed
Has Results
A Study to Evaluate Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Folate;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Placebo;   Drug: Rituximab
9 Completed
Has Results
A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: acetaminophen;   Drug: antihistamine
10 Active, not recruiting Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: Fludarabine;   Drug: Novantrone;   Drug: Decadron;   Drug: Rituximab;   Drug: Interferon;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Ara-C;   Drug: Methyl-Prednisolone;   Drug: Procarbazine;   Drug: Prednisone
11 Recruiting Study of the Bruton's Tyrosine Kinase Inhibitor in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma
Conditions: Follicular Lymphoma;   B-cell Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Ibrutinib;   Drug: rituximab
12 Active, not recruiting Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
Condition: Lymphoma
Interventions: Drug: Bendamustine;   Drug: Bortezomib;   Drug: Rituximab
13 Completed
Has Results
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Rituximab;   Drug: Anti-inflammatory drugs
14 Completed
Has Results
Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia;   Stage I Chronic Lymphocytic Leukemia;   Stage II Chronic Lymphocytic Leukemia;   Stage III Chronic Lymphocytic Leukemia;   Stage IV Chronic Lymphocytic Leukemia
Interventions: Biological: alemtuzumab;   Biological: rituximab;   Drug: fludarabine phosphate
15 Completed
Has Results
Rituximab and ABVD for Hodgkin's Patients
Condition: Lymphoma
Interventions: Drug: Rituximab;   Drug: Adriamycin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: Dacarbazine (DTIC)
16 Recruiting A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Lenalidomide;   Drug: Rituximab - CHOP;   Drug: Rituximab - CVP;   Drug: Rituximab - Bendamustine
17 Completed
Has Results
A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE)
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Rituximab;   Drug: CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone);   Drug: CVP (cyclophosphamide, vincristine, prednisone);   Drug: Analgesic/antipyretic and antihistamine drugs
18 Recruiting Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System
Conditions: Leukemia;   Lymphoid Malignancies;   Metastatic Malignant Neoplasm to the Leptomeninges
Intervention: Drug: Intrathecal Rituximab
19 Recruiting Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
Condition: Prostate Cancer
Intervention: Drug: rituximab
20 Terminated Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
Conditions: Grafting;   Renal Transplantation;   Transplantation, Kidney;   Chronic Allograft Nephropathy
Intervention: Drug: MabThera

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years